Hyperfine (HYPR) EBIT Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBIT Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 34.83% |
| 10 | Hyperfine | 94.14 Mn | 52.86 Mn | 1.98 Mn | 13.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.09% |
| Dec 31, 2025 | 17.45% |
| Sep 30, 2025 | 12.43% |
| Jun 30, 2025 | 25.49% |
| Mar 31, 2025 | 22.88% |
| Dec 31, 2024 | 25.55% |
| Sep 30, 2024 | 12.55% |
| Jun 30, 2024 | 9.40% |
| Mar 31, 2024 | -10.92% |